RH disease management: Has Doppler replaced amniotic fluid assessment?

Article

Perhaps so. Measuring middle cerebral artery (MCA) peak velocity on Doppler ultrasound is significantly better at predicting severe fetal anemia than traditional assessment via amniotic fluid ?OD450, says a well-designed clinical trial involving a large cohort of fetuses. In addition, it's noninvasive and can safely replace the AF assessment in managing Rh-alloimmunized pregnancies.

Perhaps so. Measuring middle cerebral artery (MCA) peak velocity on Doppler ultrasound is significantly better at predicting severe fetal anemia than traditional assessment via amniotic fluid ΔOD450, says a well-designed clinical trial involving a large cohort of fetuses. In addition, it's noninvasive and can safely replace the AF assessment in managing Rh-alloimmunized pregnancies.

Researchers were looking for a diagnostic test that would avoid the invasiveness of standard management-which involves evaluation by U/S for hydrops and serial amniocentesis for bilirubin values. In a prospective, international multicenter study of a cohort of consecutive Rh-D, c, E, and Fya alloimmunized pregnancies with titers at or above 64 and antigen-positive fetuses, investigators performed both the MCA Doppler and AF tests at the same time in all patients and compared results with the gold standard of fetal or cord blood sampling (at birth) to gauge the actual hemoglobin.

In a total of 165 fetuses, MCA Doppler accurately predicted severe anemia in 65/74 fetuses that were determined to be severely anemic (88%), with a specificity of 82%, and a positive predictive value of 80%. In contrast, AF had a sensitivity of 76%, specificity of 77%, and a positive predictive value of 73%.

Recent Videos
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
© 2025 MJH Life Sciences

All rights reserved.